Ambu A/S
CSE:AMBU B

Watchlist Manager
Ambu A/S Logo
Ambu A/S
CSE:AMBU B
Watchlist
Price: 100.5 DKK 2.34% Market Closed
Market Cap: 26.8B DKK

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Ambu A/S

Revenue
5.8B DKK
Cost of Revenue
-2.3B DKK
Gross Profit
3.5B DKK
Operating Expenses
-2.7B DKK
Operating Income
792m DKK
Other Expenses
-422m DKK
Net Income
370m DKK

Margins Comparison
Ambu A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
Ambu A/S
CSE:AMBU B
26.8B DKK
60%
14%
6%
US
Abbott Laboratories
NYSE:ABT
220.2B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
177.2B USD
67%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
157.1B USD
69%
19%
12%
US
Stryker Corp
NYSE:SYK
154B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
119.2B USD
66%
20%
14%
DE
Siemens Healthineers AG
XETRA:SHL
53.8B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
53.2B USD
45%
13%
7%
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
79%
28%
75%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.8B USD
61%
29%
23%
US
Resmed Inc
NYSE:RMD
40.5B USD
59%
32%
26%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Ambu A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Ambu A/S
CSE:AMBU B
26.8B DKK
7%
5%
13%
11%
US
Abbott Laboratories
NYSE:ABT
220.2B USD
32%
18%
12%
21%
US
Intuitive Surgical Inc
NASDAQ:ISRG
177.2B USD
16%
14%
16%
15%
US
Boston Scientific Corp
NYSE:BSX
157.1B USD
10%
5%
10%
8%
US
Stryker Corp
NYSE:SYK
154B USD
14%
7%
15%
11%
IE
Medtronic PLC
NYSE:MDT
119.2B USD
9%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
53.8B EUR
11%
4%
9%
6%
US
Becton Dickinson and Co
NYSE:BDX
53.2B USD
6%
3%
6%
5%
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
49%
37%
15%
18%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.8B USD
59%
27%
51%
32%
US
Resmed Inc
NYSE:RMD
40.5B USD
26%
18%
25%
21%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less